Enzalutamide Pill

DRUG2 trials

Sponsors

Andreas Josefsson, Partner Therapeutics, Inc.

Conditions

COVID-19Corona Virus InfectionMetastatic Castration-resistant Prostate CancerNSCLC Harboring NRG1 Fusion

Phase 2

Enzalutamide Treatment in COVID-19

TerminatedNCT04475601

Andreas JosefssonCorona Virus Infection, COVID-19

Start: 2020-07-15End: 2021-05-29Updated: 2022-06-02

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

TerminatedNCT05588609

Partner Therapeutics, Inc.Metastatic Castration-resistant Prostate Cancer, NSCLC Harboring NRG1 Fusion

Start: 2022-11-17End: 2025-07-03Updated: 2026-04-27

Related Papers

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.

2021-03-166 citations